A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multicellular tumor spheroids: An underestimated tool is catching up again
Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.012 · Cited by 1,674 · cited 3×
“Larger spheroids can show signs of necrosis in the center due to hypoxia (Hirschhaeuser et al. 2010).”
BackgroundInfluentialGodoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280 · cited 2×
“…hard plastic surfaces. various 3D hepatocyte models have shown a significant improvement in maintaining the morphological and functional characteristics of liver tissue (Fey and Wrzesinski 2012; Godoy et al. 2013; Gunness et al. 2013; nakamura et al. 2011; Tostoes et al. 2012; Zhang et al. 2010).”
BackgroundKelm, J. M., Timmins, N. E., Brown, C. J., Fussenegger, M., & Nielsen, L. K. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10655 · Cited by 934
Predicting in vivo drug interactions from in vitro drug discovery data
Wienkers, L. C., & Heath, T. G. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1851 · Cited by 904
Wilkening, S., Stahl, F., & Bader, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1035 · Cited by 794 · cited 4×
“However, in conventional 2D cultures, HepG2 cells express low levels of cytochrome P450 (CyP450) enzymes (Wilkening et al. 2003) and the xenobiotic receptors that regulate the expression of drug metabolic enzymes (Kanno and Inouye 2010; naspinski et al.”
BackgroundInfluentialCytochrome P450s and other enzymes in drug metabolism and toxicity
Guengerich, F. P. (2006) · The AAPS Journal · doi:10.1208/aapsj080112 · Cited by 624
Fattinger, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114667 · Cited by 509
Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury
Xu, J. J., Henstock, P. V., Dunn, M. C., Smith, A. R., Chabot, J. R., & de Graaf, D. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn109 · Cited by 492
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review
Silva, M. F. B., Aires, C. C. P., Luis, P. B. M., Ruiter, J. P. N., IJlst, L., Duran, M., Wanders, R. J. A., & Tavares de Almeida, I. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0841-x · Cited by 382
Cited by
Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development
Ronaldson-Bouchard, K., & Vunjak-Novakovic, G. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.02.011 · Cited by 657
“Liver OOCs contain hepatocytes and fibroblasts arranged in meaningful ways by patterning (Khetani and Bhatia, 2008; Cho et al., 2010) or cultured in aggregates (Ramaiahgari et al., 2014; Bhise et al., 2016).”
BackgroundMicrofluidic 3D cell culture: from tools to tissue models
van Duinen, V., Trietsch, S. J., Joore, J., Vulto, P., & Hankemeier, T. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.05.002 · Cited by 500
“Furthermore, cells cultured in 3D show important hallmarks of tissues in vivo , such as for example bile duct formation in liver spheroids [5] and milk protein secretion by mammary epithelial cells [4].”
Three-dimensional cell culture systems as an in vitro platform for cancer and stem cell modeling
Chaicharoenaudomrung, N., Kunhorm, P., & Noisa, P. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i12.1065 · Cited by 360
Ning, C., Wang, X., Li, L., Zhu, Y., Li, M., Yu, P., Zhou, L., Zhou, Z., Chen, J., Tan, G., et al. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00258 · Cited by 344
Breslin, S., & O’Driscoll, L. (2016) · Oncotarget · doi:10.18632/oncotarget.9935 · Cited by 311
Weaver, R. J., Blomme, E. A., Chadwick, A. E., Copple, I. M., Gerets, H. H. J., Goldring, C. E., Guillouzo, A., Hewitt, P. G., Ingelman-Sundberg, M., Jensen, K. G., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0048-x · Cited by 249
Self-citationLauschke, V. M., Hendriks, D. F. G., Bell, C. C., Andersson, T. B., & Ingelman-Sundberg, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00150 · Cited by 241
Three‐dimensional cell culture models for anticancer drug screening: Worth the effort?
Verjans, E., Doijen, J., Luyten, W., Landuyt, B., & Schoofs, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26052 · Cited by 212
Bell, C. C., Lauschke, V. M., Vorrink, S. U., Palmgren, H., Duffin, R., Andersson, T. B., & Ingelman-Sundberg, M. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074369 · Cited by 201
“Notably, previous studies have demonstrated improved phenotypes, functionality, and sensitivity to various hepatotoxins in spheroid culture systems of hepatic cell lines (Fey and Wrzesinski, 2012; Gunness et al., 2013; Ramaiahgari et al., 2014), stem cell–derived HLCs (Takayama et al.”
BackgroundCompetency of different cell models to predict human hepatotoxic drugs
Gómez-Lechón, M. J., Tolosa, L., Conde, I., & Donato, M. T. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.967680 · Cited by 199
“Similarly, new culture systems of HepG2 or HepaRG cell spheroids with improved properties for safety assessment studies have been developed [69,80] and further improvements in hepatotoxicity predictions of these in vitro approaches have been suggested by incorporating co-cultures with other hepatic cells (Kupffer cell…”
BackgroundInfluentialToxicology Strategies for Drug Discovery: Present and Future
Blomme, E. A. G., & Will, Y. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00407 · Cited by 194
Mazzocchi, A., Soker, S., & Skardal, A. (2019) · Applied Physics Reviews · doi:10.1063/1.5056188 · Cited by 168
A critical perspective on 3D liver models for drug metabolism and toxicology studies
Serras, A. S., Rodrigues, J. S., Cipriano, M., Rodrigues, A. V., Oliveira, N. G., & Miranda, J. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.626805 · Cited by 138
3D spheroid cultures improve the metabolic gene expression profiles of HepaRG cells
Takahashi, Y., Hori, Y., Yamamoto, T., Urashima, T., Ohara, Y., & Tanaka, H. (2015) · Bioscience Reports · doi:10.1042/bsr20150034 · Cited by 118
Zhou, Y., Shen, J. X., & Lauschke, V. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01093 · Cited by 85
“…(Gaskell et al., 2016) Spheroid HepaRG No Single 24 h Monoculture 7.62 (Wang et al., 2015) Spheroid HepG2 Hydrogel Repeated 6 days Monoculture ~9.4 (Ramaiahgari et al., 2014) Spheroid hiPSC/ hESC-HLC Galactosylated cellulosic sponge Single 24 h Monoculture >10 (Tasnim et al., 2016) Spheroid…”
BackgroundMethodInfluentialLiver three-dimensional cellular models for high-throughput chemical testing
Yang, S., Ooka, M., Margolis, R. J., & Xia, M. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100432 · Cited by 75
Štampar, M., Breznik, B., Filipič, M., & Žegura, B. (2020) · Cells · doi:10.3390/cells9122557 · Cited by 70
Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury
Lin, C., & Khetani, S. R. (2016) · BioMed Research International · doi:10.1155/2016/1829148 · Cited by 66
3D human liver spheroids for translational pharmacology and toxicology
Ingelman‐Sundberg, M., & Lauschke, V. M. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13587 · Cited by 62
Hussein, K. H., Park, K. M., Ghim, J. H., Yang, S. R., & Woo, H. M. (2016) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.33384 · Cited by 56
De Simone, U., Roccio, M., Gribaldo, L., Spinillo, A., Caloni, F., & Coccini, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071993 · Cited by 55
“Groups that have started to apply 3D culture systems for the toxicity assessment in identifying hepatotoxic compounds have also applied this tool with repeated dosing regimens [48,49] providing the suitability of using this new in vitro high-throughput model for the prediction of hepatotoxicity.”
BackgroundLee, H.-J., Son, M. J., Ahn, J., Oh, S. J., Lee, M., Kim, A., Jeung, Y.-J., Kim, H.-G., Won, M., Lim, J. H., et al. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.09.041 · Cited by 47
Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery
Fu, J., Qiu, H., & Tan, C. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041300 · Cited by 42
“They have diverse differentiation functions and stable phenotypes, but the CYP450 expression level is not as high as that of HepaRG cells when HepaRG cells differentiate into hepatocytes [62,63].”
BackgroundIn Vitro Three‐Dimensional Liver Models for Nanomaterial DNA Damage Assessment
Llewellyn, S. V., Niemeijer, M., Nymark, P., Moné, M. J., van de Water, B., Conway, G. E., Jenkins, G. J. S., & Doak, S. H. (2021) · Small · doi:10.1002/smll.202006055 · Cited by 41
Hong, S., & Song, J. M. (2021) · Biomaterials Science · doi:10.1039/d1bm00749a · Cited by 39
Sun, B., Liang, Z., Wang, Y., Yu, Y., Zhou, X., Geng, X., & Li, B. (2024) · Toxicology · doi:10.1016/j.tox.2024.153829 · Cited by 30
Tanaka-yachi, R., Aizawa, K., Shimizu, K., Akutsu, H., & Nakamura, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-25777-z · Cited by 4
Metadata
- Authors
- Ramaiahgari, S. C., den Braver, M. W., Herpers, B., Terpstra, V., Commandeur, J. N. M., van de Water, B., & Price, L. S.
- Venue
- Archives of Toxicology
- Published
- 2014-03-06
- Volume
- 88
- Issue
- 5
- Pages
- 1083-95
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W2109850567
- Cited by
- 364
- References
- 47
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.